Search

everythinglearnresearchcommunity

for

Search:↓

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Minoxidil helps hair regrowth in traction alopecia.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

New drug delivery methods can make natural compounds more effective and stable.

Stem cell therapy may help treat tough hair loss cases.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Minoxidil effectively treats hair loss, with better results in women.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.